Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy Isatuximab Plus Pomalidomide and DexamethasoneAssociation for Patients With AL Amyloidosis Not in VG ...
A Phase 2, Open Label, Multicenter, Single-stage Study to Evaluate the Efficacy of Isatuximab Plus Pomalidomide and Dexamethasone (IPd), in Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy A Phase 2, Open Label, Multicenter, Single-stage Study to Evaluate the Efficacy of Isatuximab Plus P ...
A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis A Phase I/II Trial of Pomalidomide and Dexamethasonein Subjects With Previously-Treated AL Amyloidos ...
A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis A Phase I/II Trial of Pomalidomide and Dexamethasonein Subjects With Previously-Treated AL Amyloidos ...
Treatment with pomalidomide and dexamethasone for previously treated patients with AL amyloidosis.
An open-label, phase II study of Pomalidomide and Dexamethasone (PDex) for previously treated patients with AL amyloidosis - PDex An open-label, phase II study of Pomalidomide and Dexamethasone(PDex) for previously treated patient ...
Previously treated AL amyloidosis MedDRA version: 14.1;Level: PT;Classification code 10002022;Term: Amyloidosis;System Organ Class: 10021428 - Immune system disorders;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15] Previously treated AL amyloidosis MedDRA version: 14.1;Level: PT;Classification code 10002022;Term: ...
Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis
An Open-label, Phase II Study of Pomalidomide and Dexamethasone (PDex) for Previously Treated Patients With AL Amyloidosis. An Open-label, Phase II Study of Pomalidomide and Dexamethasone(PDex) for Previously Treated Patient ...